Sign In
Buy AQST
$4.03
+0.100 (+2.54%)
At Close: Jun 03, 2026
Aquestive Therapeutics (AQST) Reports Q3 Loss, Tops Revenue Estimates
07:54pm, Tuesday, 02'nd Nov 2021
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 7.50% and 10.45%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the sto
Aquestive Therapeutics (AQST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:41pm, Tuesday, 26'th Oct 2021
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WARREN, N.J., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
WARREN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
Aquestive Therapeutics to Participate in 12th Annual Wedbush PacGrow Healthcare Virtual Conference
08:00am, Friday, 06'th Aug 2021
WARREN, N.J., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript
11:34am, Wednesday, 04'th Aug 2021
Aquestive Therapeutics' (AQST) CEO Keith Kendall on Q2 2021 Results - Earnings Call Transcript
Aquestive Therapeutics (AQST) Reports Q2 Loss, Tops Revenue Estimates
08:35pm, Tuesday, 03'rd Aug 2021
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 21.43% and 44.42%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Aquestive Therapeutics Reports Second Quarter 2021 Financial Results, Provides Business Update and Raises Full Year Revenue Guidance
05:55pm, Tuesday, 03'rd Aug 2021
WARREN, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pati
Earnings Preview: Aquestive Therapeutics (AQST) Q2 Earnings Expected to Decline
04:07pm, Tuesday, 27'th Jul 2021
Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks To Watch With The Stock Market Down Today
04:03pm, Monday, 19'th Jul 2021
Which Penny Stocks Are Investors Watching After the Stock Market Crash? The post 4 Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Information |
Aquestive Therapeutics Announces FDA Acceptance of New Drug Application (NDA) Resubmission for Libervant™ (diazepam) Buccal Film
09:29am, Monday, 19'th Jul 2021
WARREN, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
Aquestive Therapeutics Resubmits New Drug Application for Libervant™ (diazepam) Buccal Film
08:00am, Thursday, 24'th Jun 2021
WARREN, N.J., June 24, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
Aquestive Therapeutics: Bullish Outlook Continues To Harden
01:30pm, Wednesday, 23'rd Jun 2021
Aquestive Therapeutics is moving closer to resubmitting Libervant's NDA. The company expects to submit the NDA by the end of this month, which could put the PDUFA date in 2021. Aquestive continues to
Aquestive Therapeutics Announces Leadership Transition of Chief Financial Officer
09:15am, Monday, 21'st Jun 2021
WARREN, N.J., June 21, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences
08:30am, Wednesday, 09'th Jun 2021
WARREN, N.J., June 09, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address pat
